Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene -- the largest gene on the X chromosome -- which affects one...
Keep Reading →
August 27 - News
While many investors worried about the Nasdaq's three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn't have come back up.
Keep Reading →
August 26 - News
Shares of small biotech ChemoCentryx Inc (NASDAQ:CCXI) collapsed by 44% in early trading on Friday before paring the losses somewhat.
Keep Reading →
August 23 - Dividend Stocks, News
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
Keep Reading →
August 23 - News
To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.
Keep Reading →
August 22 - News
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Keep Reading →
August 22 - News
Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of an era lost to time.
Keep Reading →
August 21 - News
For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Keep Reading →
August 20 - News
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment, because these are exciting...
Keep Reading →
August 20 - News
With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
August 19 - News
A strong week for investors ended especially well in China, as Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) index jumped by 3.3% for the week.
Keep Reading →
August 19 - News
This could have been an enormously more difficult effort. I started out with the goal to identify the three best stocks in health care to buy and hold for years, even decades.
Keep Reading →
August 19 - News
On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)'s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc (NASDAQ:SRPT)'s competing Duchenne...
Keep Reading →
August 17 - News
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Keep Reading →
August 13 - News
Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.
Keep Reading →
August 12 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through travel agencies.
Keep Reading →
August 12 - News
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
Keep Reading →
August 12 - News
Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories.
Keep Reading →
August 11 - News
Baseball star Alex Rodriguez had an opportunity to be perhaps the greatest player of the past decade or even longer -- that was until he threw it all away by admitting to steroid...
Keep Reading →
August 10 - News
Currently existing immunomodulatory drugs that treat Multiple Sclerosis only work to treat relapse or attacks, manage symptoms, or modify the course of the disease.
Keep Reading →
August 8 - News
Believe it or not, 2013 is getting close to being two-thirds of the way over. Many pharmaceutical firms have enjoyed great stock returns and nice profits thus far in the year.
Keep Reading →
August 6 - News
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market.
Keep Reading →
August 1 - News
To most people, cigarettes are often associated with lung cancer.
Keep Reading →
July 30 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of the violation of Chinese laws wherein the company’s key officials have used around 700 agencies and firms for increasing...
Keep Reading →
July 29 - News
The study included 184 patients with mild-to-moderate persistent allergic asthma.
Keep Reading →
July 29 - News
It's been a long time since China's double-digit economic growth became the envy of nations across the world. Since then, the Chinese economy has slowed.
Keep Reading →
July 29 - News
Investors wondered for months if Sarepta Therapeutics Inc (NASDAQ:SRPT) would pursue accelerated approval for Duchenne muscular dystrophy, or DMD, drug eteplirsen.
Keep Reading →
July 25 - News
Diversification is a subject most investors understand well.
Keep Reading →
July 24 - News
The healthcare sector has been one of the best sectors for dividend hunters -- most of the companies operating in the sector generate massive cash flow and payout a large chunk...
Keep Reading →
July 24 - News
By age 35, around two-thirds of all American men will have begun to experience androgenetic alopecia, more commonly known as male pattern baldness.
Keep Reading →
July 24 - News
There's little denying that the technological, research, and medicinal aspects of patient care are improving at breakneck speed.
Keep Reading →
July 22 - News
Most recently, executives working for the U.K.-based GlaxoSmithKline plc (ADR) (NYSE:GSK) in China have been accused of, and confessed to, serious corruption and tax-related ...
Keep Reading →
July 19 - News
Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide) in B-Cell chronic lymphomatic...
Keep Reading →
July 18 - News
Over 13 million Americans have it. More than 120,000 of them die every year.
Keep Reading →
July 17 - News
With all of the factors we have to worry about in our everyday lives, it is somewhat a wonder that we're not only able to survive, but thrive, as a society.
Keep Reading →
July 15 - News
If you thought the fireworks ended after the Fourth of July celebrations last week, think again.
Keep Reading →
July 15 - News
A year ago, AVI BioPharma underwent a process from being an $85 million biotechnology company to a $1.3 billion company called Sarepta Therapeutics Inc (NASDAQ:SRPT).
Keep Reading →
July 15 - News
The Centers for Disease Control recently released a study showing that the introduction of human papillomavirus vaccines has significantly reduced infection rates among teenaged...
Keep Reading →
July 15 - News
At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.
Keep Reading →
July 12 - News
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Keep Reading →
July 10 - News
At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.
Keep Reading →
July 10 - News
"More means less." Amarin Corporation plc (ADR) (NASDAQ:AMRN) demonstrated this seemingly contradictory maxim today following its announcement of a new public offering.
Keep Reading →
July 9 - News
After more than a year, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’ weight-loss drug Belviq has finally launched.
Keep Reading →
July 9 - News
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 8 - News
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
Keep Reading →
July 8 - News
Investors who buy stock in the major pharmaceutical companies likely do so because of several factors, including steady growth, modest valuations, and high dividend yields.
Keep Reading →
July 5 - News
When screening for health-care dividend stocks, it's tempting to look for the ones with the highest yield.
Keep Reading →
July 5 - News
